Health Canada authorizes mRNA vaccine trial for Ebola virus causing huge outbreak in Congo
• Health Canada has authorized Moderna to begin a clinical trial for an mRNA vaccine targeting the Bundibugyo strain of the Ebola virus. • The trial aims to combat a significant and ongoing outbreak of the virus currently surging throughout the Democratic Republic of the Congo. • This authorization is critical as it leverages mRNA technology to provide a rapid response to a deadly pathogen in a region facing a public health crisis.
cbc.ca









